Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Akorn | Location not on file | Makes it, tests it, packages it, labels it and sterilizes it | Not inspected on record |
Recalls
- Feb 22, 2019 · Class II · Akorn, Inc.
Failed Impurities/Degradation Specifications: High Out-of-Specification (OOS) results for Individual and Total Impurities that have been identified at the 18 months stability testing time point.
Lots: Lot 7B71A, Exp 01/2020 - Oct 8, 2018 · Class II · Akorn, Inc.
Presence of Particulate Matter: Crystalline particles were noticed at the 24 month clarity testing.
Lots: Lots: 6C02A Exp. 02/19; 5K42A Exp. 09/2018; 7D47A Exp. 03/2020
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Gentamicin: every company that makes it
- Form
- solution/ drops
- Strength
- 3 mg per 1 mL
- Approval
- ANDA ANDA064163
- On the market since
- Dec 13, 2006
- Package NDCs
17478-283-10- Official label
- DailyMed (National Library of Medicine), updated Jan 27, 2022
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?